ZAGARIA, ANTONELLA
 Distribuzione geografica
Continente #
NA - Nord America 8.174
EU - Europa 3.888
AS - Asia 2.760
SA - Sud America 622
Continente sconosciuto - Info sul continente non disponibili 320
AF - Africa 173
OC - Oceania 2
Totale 15.939
Nazione #
US - Stati Uniti d'America 7.939
DE - Germania 1.228
SG - Singapore 1.112
IT - Italia 754
CN - Cina 636
RU - Federazione Russa 523
BR - Brasile 476
SE - Svezia 415
GB - Regno Unito 327
HK - Hong Kong 315
VN - Vietnam 169
FI - Finlandia 165
FR - Francia 165
CA - Canada 99
IN - India 96
BD - Bangladesh 94
UA - Ucraina 80
CI - Costa d'Avorio 77
ID - Indonesia 45
AR - Argentina 43
ZA - Sudafrica 40
IQ - Iraq 39
MX - Messico 39
PK - Pakistan 36
CO - Colombia 32
PL - Polonia 32
JP - Giappone 31
BE - Belgio 30
TR - Turchia 30
LT - Lituania 27
VE - Venezuela 25
CZ - Repubblica Ceca 22
PH - Filippine 21
ES - Italia 19
NL - Olanda 17
UZ - Uzbekistan 17
CR - Costa Rica 16
MY - Malesia 16
SA - Arabia Saudita 16
AT - Austria 15
IE - Irlanda 15
MA - Marocco 14
SV - El Salvador 13
CL - Cile 12
EC - Ecuador 12
GT - Guatemala 12
NP - Nepal 11
JM - Giamaica 10
RO - Romania 10
TN - Tunisia 10
AZ - Azerbaigian 9
HN - Honduras 9
NI - Nicaragua 9
PE - Perù 9
TT - Trinidad e Tobago 9
IL - Israele 8
KE - Kenya 8
CW - ???statistics.table.value.countryCode.CW??? 7
ET - Etiopia 7
IR - Iran 7
PT - Portogallo 7
RS - Serbia 7
JO - Giordania 6
KZ - Kazakistan 6
LB - Libano 6
PY - Paraguay 6
CH - Svizzera 5
EG - Egitto 5
GP - Guadalupe 5
PS - Palestinian Territory 5
DZ - Algeria 4
HR - Croazia 4
KG - Kirghizistan 4
KR - Corea 4
PR - Porto Rico 4
TH - Thailandia 4
AE - Emirati Arabi Uniti 3
BG - Bulgaria 3
BO - Bolivia 3
EE - Estonia 3
GE - Georgia 3
GR - Grecia 3
AL - Albania 2
BY - Bielorussia 2
HT - Haiti 2
HU - Ungheria 2
MT - Malta 2
PA - Panama 2
SN - Senegal 2
SR - Suriname 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
AU - Australia 1
BB - Barbados 1
BH - Bahrain 1
BM - Bermuda 1
BN - Brunei Darussalam 1
BZ - Belize 1
CY - Cipro 1
DK - Danimarca 1
Totale 15.606
Città #
Ashburn 953
Fairfield 837
Singapore 620
San Jose 535
Chandler 502
Woodbridge 488
Houston 395
Seattle 390
Hong Kong 314
Nyköping 313
Cambridge 306
New York 266
Wilmington 266
Milan 246
Beijing 229
Ann Arbor 219
Los Angeles 177
Jacksonville 165
Council Bluffs 138
Munich 120
Lauterbourg 88
Dallas 82
Rome 82
Lawrence 81
Roxbury 80
Abidjan 77
Nanjing 77
Bari 74
Boardman 74
Helsinki 71
Brooklyn 70
Santa Clara 59
Ho Chi Minh City 55
Falkenstein 54
Des Moines 52
São Paulo 49
Princeton 42
Moscow 38
London 35
Columbus 33
Phoenix 32
Turku 32
Hanoi 31
Jakarta 31
Atlanta 30
Frankfurt am Main 30
Nanchang 30
Brussels 29
Buffalo 29
Chicago 29
Redwood City 29
San Diego 29
Warsaw 29
Montreal 28
Tokyo 28
Inglewood 27
Marseille 26
Denver 23
Dong Ket 23
Paris 23
Toronto 22
Johannesburg 21
Chennai 20
Naples 19
Changsha 17
Rio de Janeiro 17
Shanghai 17
Figino 16
Hebei 16
Nuremberg 16
Tashkent 16
Orem 15
San José 15
Baghdad 14
Boston 14
Dublin 14
Falls Church 14
Guangzhou 14
Mexico City 14
Poplar 14
Shenyang 14
Turin 14
Vilnius 14
Lahore 13
North Bergen 13
Pune 13
San Francisco 13
Belo Horizonte 12
Brno 12
Dhaka 12
The Dalles 12
Tianjin 12
Brasília 11
Portsmouth 11
Stockholm 11
Jiaxing 10
Manchester 10
Medellín 10
Ankara 9
Baku 9
Totale 9.880
Nome #
Absolute quantification of the pretreatment PML-RARA transcript defines the relapse risk in acute promyelocytic leukemia. 263
BCR–ABL1 e6a2 transcript in chronic myeloid leukemia: biological features and molecular monitoring by droplet digital PCR 258
A fluorescence in situ hybridization study of complex t(9;22) in two chronic myelocytic leukemia cases with a masked Philadelphia chromosome 244
TP53 gene mutation analysis in chronic lymphocytic leukemia by nanopore MinION sequencing 230
ADAMTS2 gene dysregulation in T/myeloid mixed phenotype acute leukemia. 229
Monosomal karyotype in myeloid neoplasias: a literature review 229
Feasibility of Optical Genome Mapping in Cytogenetic Diagnostics of Hematological Neoplasms: A New Way to Look at DNA 221
Design and MinION testing of a nanopore targeted gene sequencing panel for chronic lymphocytic leukemia 221
Droplet digital PCR for the quantification of Alu methylation status in hematological malignancies 220
A chronic myelocytic leukemia case bearing deletions on the three chromosomes involved in a variant t(9;22;11) 219
Breakpoint characterization of der(9) deletions in chronic myeloid leukemia patients 216
Droplet Digital PCR Is a Robust Tool for Monitoring Minimal Residual Disease in Adult Philadelphia-Positive Acute Lymphoblastic Leukemia 211
Lymphoid Enhancer Binding Factor-1 (LEF1) expression as a prognostic factor in adult acute promyelocytic leukemia. 208
MYEOV gene overexpression in primary plasma cell leukemia with t(11;14)(q13;q32) 207
Droplet digital PCR analysis of NOTCH1 gene mutations in chronic lymphocytic leukemia 205
A novel chromosomal translocation t(3;7)(q26;q21)in myeloid leukemia resulting in overexpression of EVI1 204
5'RUNX1-3'USP42 chimeric gene in acute myeloid leukemia can occur through an insertion mechanism rather than translocation and may be mediated by genomic segmental duplications. 204
Droplet Digital PCR Is a Reliable Tool for Monitoring Minimal Residual Disease in Acute Promyelocytic Leukemia 202
Overexpression of the LSAMP and TUSC7 genes in acute myeloid leukemia following microdeletion/duplication of chromosome 3 201
STAT5B GENE DYSREGULATION CORRELATES WITH LEF1 GENE EXPRESSION IN ADULT ACUTE PROMYELOCYTIC LEUKEMIA 198
Acute myeloid leukemia with t(16;16) (p13;q22) showing a new CBFB-MYH11 fusion transcript associated with an atypical leukemic blasts morphology. 195
Downregulated expression of genes mapping on chromosome 9 in chronic myeloid leukemia cases bearing genomic deletions on der(9) 192
Molecular cytogenetic study of instability at 1q21∼q32 in adult acute lymphoblastic leukemia 192
Genomic BCR-ABL1 breakpoint characterization by a multistrategy approach for "personalized monitoring" of residual disease in chronic myeloid leukemia patients 189
A complex and cryptic intrachromosomal rearrangement generating the FIP1L1_PDGFRA in adult acute myeloid leukemia 188
A 76-kb duplicon maps close to the BCR gene on chromosome 22 and the ABL gene on chromosome 9: possible involvement in the genesis of the Philadelphia chromosome translocation 187
A new recurrent chromosomal translocation t(3;11)(q13;q14) in myelodysplastic syndromes associated with overexpression of the ILDR1 gene. 186
Myelodysplastic syndrome with 5q deletion following IgM monoclonal gammopathy, showing gene mutation MYD88 L265P. 182
Pericentric chromosome 8 inversion associated with the 5'RUNX1/3'CBFA2T1 gene in acute myeloid leukemia cases 179
The Pleiotropic Role of Retinoic Acid/Retinoic Acid Receptors Signaling: From Vitamin A Metabolism to Gene Rearrangements in Acute Promyelocytic Leukemia 176
Derivative chromosome 9 deletions in chronic myeloid leukemia are associated with loss of tumor suppressor genes 174
Decreased TET2 gene expression during chronic myeloid leukemia progression 173
A novel t(4;16)(q25;q23.1) associated with EGF and ELOVL6 deregulation in acute myeloid leukemia 173
Skin lesions in chronic myeloid leukemia patients during dasatinib treatment 173
Mutational analysis in BCR-ABL1 positive leukemia by deep sequencing based on nanopore MinION technology 170
A novel translocation t(14;15)(q32;q24) bearing deletion on der(14) in Philadelphia-positive chronic myeloid leukemia 169
BCL6 corepressor gene dysregulation due to chromosomal translocation in acute myeloid leukemia: a new mechanism based on long non-coding RNA dislocation? 169
"Home-brew" FISH assay shows higher efficiency than BCR-ABL dual color, dual fusion probe in detecting microdeletions and complex rearrangements associated with t(9;22) in chronic myeloid leukemia 168
ABSOLUTE QUANTIFICATION OF THE PRETREATMENT PML-RARA MOLECULAR TRANSCRIPT DEFINES THE RELAPSE RISK IN ACUTE PROMYELOCYTIC LEUKEMIA 168
Next-Generation Sequencing in Acute Lymphoblastic Leukemia 166
RARA and RARG Gene Downregulation Associated with EZH2 Mutation in Acute Promyelocytic-Like Morphology Leukemia 164
Non random distribution of genomic features in breakpoint regions involved in chronic myeloid leukemia cases with variant t(9;22) or additional chromosomal rearrangements 164
Insertions generating the 5'RUNX1/3'CBFA2T1 gene in acute myeloid leukemia cases show variable breakpoints 161
Erythrocytosis with JAK2 GGCC_46/1 haplotype and without JAK2 V617F mutation is associated with CALR rs1049481_G allele 159
The Behavior of Cytogenetic/Molecular Markers Associated with JAK2 Mutation Status Before and After Primary Myelofibrosis Progression Supports the Hypothesis of the Leukemic Clone's Independence From the JAK2 Mutation 158
CPX-351 in acute myeloid leukemia: can a new formulation maximize the efficacy of old compounds? 157
A 76kb interchromosomal duplicon maps close to BCR gene on chromosome 22 and to ABL gene on chromosome 9: possible involvement in the genesis of the Philadelphia-chromosome translocation 156
Molecular cytogenetic findings supporting the evidence of a biclonal origin in acute myeloid leukemia 155
Extramedullary molecular evidence of the 5'KIAA1509/3'PDGFRB fusion gene in chronic eosinophilic leukemia 155
ROLE OF THE TRANSCRIPTION FACTOR CTCF IN THE PATHOGENESIS OF MYELODYSPLASTIC SYNDROMES 154
IgG-lymphoplasmacytic lymphoma following polycythemia vera: JAK2 V617F and MYD88 L265P mutations separated in the same house. 150
Clonal Hematopoiesis at the Crossroads of Inflammatory Bowel Diseases and Hematological Malignancies: A Biological Link? 149
Chronic Myeloid Leukemia with Variant t(9;22) Shows Dysregulated Expression of Genes Included in Pivotal Cellular Pathways 149
SETBP1 dysregulation in congenital disorders and myeloid neoplasms 147
DROPLET DIGITAL PCR ANALYSIS FOR DIAGNOSIS AND MINIMAL RESIDUAL DISEASE MONITORING IN ADULT PH plus ACUTE LYMPHOBLASTIC LEUKEMIA 146
Genomic deletions on other chromosomes involved in variant t(9;22) chronic myeloid leukemia cases 144
Submicroscopic deletions in an acute myelocytic leukemia case with a four-way t(8;11;16;21) 143
Genomic segmental duplications on the basis of the t(9;22) rearrangement in chronic myeloid leukemia 143
SETBP1 and miR_4319 dysregulation in primary myelofibrosis progression to acute myeloid leukemia. 142
A novel t(3;9)(q21.2; p24.3) associated with SMARCA2 and ZNF148 genes rearrangement in myelodysplastic syndrome 142
ETV6 mutations and loss in AML-M0 141
Molecular Cytogenetic Characterization of a Complex Rearrangement Involving Chromosomes 9 and 22 in a Case of Ph Negative Chronic Myeloid Leukemia 139
Deletions on der(9) chromosome in adult Ph-positive acute lymphoblastic leukemia occur with a frequency similar to that observed in chronic myeloid leukemia 139
Droplet Digital PCR Analysis for Diagnosis and Minimal Residual Disease Monitoring in Adult Ph plus Acute Lymphoblastic Leukemia 138
Digital pcr: A reliable tool for analyzing and monitoring hematologic malignancies 137
The JAK2 GGCC (46/1) haplotype in myeloproliferative neoplasms: Causal or random? 133
MIRN199B downregulation in chronic myeloid leukaemia is associated with deletions on der(9) 131
Epitranscriptomics in normal and malignant hematopoiesis 124
Molecular cytogenetics characterization of a novel translocation involving chromosomes 17 and 19 in a Ph+ adult acute lymphoblastic leukemia 119
Can the new and old drugs exert an immunomodulatory effect in acute myeloid leukemia? 117
Exploring the Potential of Eltrombopag: Room for More? 116
Molecular cytogenetic characterization of deletions on der(9) in chronic myelocytic leucemia 116
Single-Cell Sequencing: Ariadne's Thread in the Maze of Acute Myeloid Leukemia 115
null 115
null 107
Nanopore targeted sequencing for rapid gene mutations detection in acute myeloid leukemia 107
IKAROS in Acute Leukemia: A Positive Influencer or a Mean Hater? 106
JAK2 V617f in chronic myeloid leukemia: driving force or passive bystander? 105
Optical Genome Mapping as a Tool to Unveil New Molecular Findings in Hematological Patients with Complex Chromosomal Rearrangements 104
Nanopore sequencing sheds a light on the FLT3 gene mutations complexity in acute promyelocytic leukemia 104
Second Cancer Onset in Myeloproliferative Neoplasms: What, When, Why? 101
null 100
t(15;17) in acute promyelocytic leukemia is not associated with submicroscopic deletions on der(17) 99
Centromeric fragment of chromosome 7 in atypical chronic myeloid leukemia with the SET binding protein 1 gene mutation. 99
Clonal hematopoiesis in clinical practice: walking a tightrope 98
Clonal hematopoiesis onset in chronic myeloid leukemia patients developing an adverse cardiovascular event 98
HMGA proteins in hematological malignancies 97
Nanopore Sequencing in Blood Diseases: A Wide Range of Opportunities 97
The Role of NLRP3, a Star of Excellence in Myeloproliferative Neoplasms 95
null 95
null 95
Droplet digital PCR assay for quantifying of CALR mutant allelic burden in myeloproliferative neoplasms 95
Monitoring minimal residual disease by ddPCR in acute lymphoblastic leukemia associated with the FGFR1 gene rearrangement 90
IRF4 Gene Expression on the Trail of Molecular Response: Looking at Chronic Myeloid Leukemia from Another Perspective 88
null 87
The double deceit generated by an insertion mechanism in chronic myeloid leukemia with t(9;9;22) 87
IRF4 dysregulation in chronic myelomonocytic leukemia: another brick in the wall of myelodysplastic/myeloproliferative neoplasms 80
Dysregulation of mirna in leukemia: Exploiting mirna expression profiles as biomarkers 80
Molecular complexity of diffuse large B-cell lymphoma: Can it be a roadmap for precision medicine? 79
TP53 in myelodysplastic syndromes: Recent biological and clinical findings 78
Totale 15.248
Categoria #
all - tutte 60.281
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 60.281


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022574 0 0 0 0 43 84 43 28 42 63 120 151
2022/20231.261 162 195 86 91 137 174 11 151 192 7 21 34
2023/2024623 38 69 28 29 65 266 4 24 0 17 7 76
2024/20252.055 88 52 111 119 94 158 255 190 73 128 300 487
2025/20264.784 616 192 314 581 632 279 468 102 580 447 137 436
2026/20271.058 104 185 220 515 34 0 0 0 0 0 0 0
Totale 15.939